In conclusion, the activation of TGF-β/Smad3 signaling is responsible for loss of GPX4 and the development of ferroptosis-associated fibrosis in the fibrotic kidney of patients and mice with CKD. The gene discussed is GPX4; the disease is chronic kidney disease.